Dietary fiber finds place on Chinese dining tables in dawning sugar-free era
With its significant gap in adoption, China has big potential to join growing global weight management, gut health and chronic disease prevention movements LeadLeo Research Institute As the concepts…
Investors lap up China Feihe despite declining profits and revenue
The premium infant formula maker is taking a hit from China’s low birth rate, but investors may like its dividends and transition to other dairy products Key Takeaways: China Feihe…
AustAsia finds tough going as independent dairy
The recently listed company fell into the red in the first half of the year, pressured by slumping milk prices and rising feed costs Key Takeaways: AustAsia said it expects…
RELATED ARTICLES
-
From ‘magic tea’ to dietary drugs, can Besunyen reclaim its glory days？
0926.HK -
Feihe’s sliding profits point to China dairy market past its sell-by date
6186.HK
- China’s prepackaged coffee drink market enters new era of quality
-
Hengrui Pharma targets obesity drug launch after test success
1278.HK 600276.SHG
- Top Numerical tools up for Hong Kong IPO
- PomDoc offers up well-conceived but overvalued digital healthcare IPO
-
Meituan drives to Brazil in search of growth, only to crash into Chinese rival DiDi
3690.HK
